Stapokibart (CM310) is a humanized monoclonal antibody targeting IL-4Ralpha, blocking IL-4Ralpha-mediated signaling. It is used in studies of atopic dermatitis.
Purity:
96.09%
CAS Number:
[2734715-10-5]
Target:
Interleukin|||IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted